Roche Holding Company Profile (VTX:ROG)

About Roche Holding (VTX:ROG)

Roche Holding logoRoche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: VTX:ROG
  • CUSIP: N/A
  • Web: www.roche.com
Average Prices:
  • 50 Day Moving Avg: CHF 107.91
  • 200 Day Moving Avg: CHF 88.49
P/E:
  • Trailing P/E Ratio: 31.97
  • P/E Growth: 1.34
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: 16.69%
  • Return on Equity: 39.52%
  • Return on Assets: 11.24%
 

Frequently Asked Questions for Roche Holding (VTX:ROG)

What is Roche Holding's stock symbol?

Roche Holding trades on the VTX under the ticker symbol "ROG."

Where is Roche Holding's stock going? Where will Roche Holding's stock price be in 2017?

10 analysts have issued 1 year target prices for Roche Holding's stock. Their predictions range from CHF 215 to CHF 335. On average, they anticipate Roche Holding's stock price to reach CHF 273 in the next twelve months. View Analyst Ratings for Roche Holding.

Who are some of Roche Holding's key competitors?

Who are Roche Holding's key executives?

Roche Holding's management team includes the folowing people:

  • Severin Schwan, Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director
  • Alan Hippe, Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
  • Stephan Feldhaus, Member of the Enlarged Corporate Executive Committee, Head Group Communications
  • Sophie Kornowski-Bonnet, Member of the Enlarged Corporate Executive Committee, Head Roche Partnering
  • Osamu Nagayama, Member of the Enlarged Corporate Executive Committee, Chairman and Chief Executive Officer Chugai
  • John C. Reed M.D., Ph.D., Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
  • Michael David Varney, Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
  • Cristina A. Wilbur, Member of the Executive Committee, Head Group Human Resources
  • Urs Jaisli, Chief Compliance Officer
  • Gottlieb A. Keller, Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors


MarketBeat Community Rating for Roche Holding (VTX ROG)
Community Ranking:  4.5 out of 5 (    )
Outperform Votes:  174 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  195
MarketBeat's community ratings are surveys of what our community members think about Roche Holding and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Roche Holding (VTX:ROG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: CHF 273

Analysts' Ratings History for Roche Holding (VTX:ROG)
Show:
DateFirmActionRatingPrice TargetDetails
6/27/2017Deutsche Bank AGSet Price TargetBuyCHF 273View Rating Details
6/27/2017J P Morgan Chase & CoReiterated RatingBuyView Rating Details
6/27/2017Goldman Sachs Group, Inc. (The)Set Price TargetBuyCHF 335View Rating Details
6/20/2017BNP ParibasSet Price TargetNeutralCHF 250View Rating Details
6/16/2017Jefferies Group LLCSet Price TargetBuyCHF 285View Rating Details
6/13/2017Barclays PLCSet Price TargetBuyCHF 305View Rating Details
6/6/2017HSBC Holdings plcSet Price TargetSellCHF 215View Rating Details
6/6/2017Kepler Capital MarketsSet Price TargetNeutralCHF 231View Rating Details
5/29/2017Morgan StanleySet Price TargetBuyCHF 290View Rating Details
11/3/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
(Data available from 6/28/2015 forward)

Earnings

Earnings History for Roche Holding (VTX:ROG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Roche Holding (VTX:ROG)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Roche Holding (VTX:ROG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Roche Holding (VTX:ROG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Roche Holding (VTX:ROG)
Latest Headlines for Roche Holding (VTX:ROG)
Source:
DateHeadline
americanbankingnews.com logoRoche Holding Ltd. (ROG) PT Set at CHF 335 by Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - June 17 at 9:42 PM
americanbankingnews.com logoJefferies Group LLC Analysts Give Roche Holding Ltd. (ROG) a CHF 285 Price Target
www.americanbankingnews.com - June 17 at 10:28 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - June 16 at 11:58 AM
finance.yahoo.com logoSave the Date: Rogers to Host Investor Day August 17
finance.yahoo.com - June 16 at 9:24 AM
americanbankingnews.com logoBarclays PLC Analysts Give Roche Holding Ltd. (ROG) a CHF 305 Price Target
www.americanbankingnews.com - June 13 at 7:26 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 335 Price Target by Goldman Sachs Group Inc Analysts
www.americanbankingnews.com - June 11 at 12:10 PM
feeds.benzinga.com logoROCHE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Roche Holding AG To Contact The Firm
feeds.benzinga.com - June 7 at 12:07 PM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Stock Rating Reaffirmed by JPMorgan Chase & Co.
www.americanbankingnews.com - June 7 at 10:26 AM
americanbankingnews.com logoKepler Capital Markets Analysts Give Roche Holding Ltd. (ROG) a CHF 231 Price Target
www.americanbankingnews.com - June 6 at 7:32 AM
americanbankingnews.com logoDeutsche Bank AG Reiterates "CHF 273" Price Target for Roche Holding Ltd. (ROG)
www.americanbankingnews.com - June 6 at 7:32 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 215 Price Target at HSBC Holdings plc
www.americanbankingnews.com - June 6 at 7:32 AM
nasdaq.com logoS.Korea's Samsung Bioepis developing biosimilar of Roche's Lucentis - Nasdaq
www.nasdaq.com - June 2 at 2:58 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 290 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - May 29 at 10:56 PM
finance.yahoo.com logoETFs with exposure to Rogers Corp. : May 26, 2017
finance.yahoo.com - May 27 at 3:58 AM
americanbankingnews.com logoGoldman Sachs Group Inc Reiterates CHF 335 Price Target for Roche Holding Ltd. (ROG)
www.americanbankingnews.com - May 26 at 11:38 PM
nasdaq.com logoDeadly brain infection in German MS patient prompts Roche investigation - Nasdaq
www.nasdaq.com - May 24 at 8:01 PM
finance.yahoo.com logoRogers to Participate in B. Riley & Co. Annual Investor Conference
finance.yahoo.com - May 24 at 9:42 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - May 22 at 8:38 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) PT Set at CHF 320 by Barclays PLC
www.americanbankingnews.com - May 21 at 11:46 PM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 335 Price Target at Goldman Sachs Group Inc
www.americanbankingnews.com - May 21 at 11:46 PM
americanbankingnews.com logoRoche Holding's (ROG) "Buy" Rating Reaffirmed at JPMorgan Chase & Co.
www.americanbankingnews.com - May 21 at 11:08 PM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Given a CHF 305 Price Target at Jefferies Group LLC
www.americanbankingnews.com - May 21 at 3:04 PM
nasdaq.com logoImmunoGen drug moving ahead in single-agent, combination trials - Nasdaq
www.nasdaq.com - May 17 at 7:30 PM
nasdaq.com logoMerck says test shows Keytruda improves survival for bladder cancer patients - Nasdaq
www.nasdaq.com - May 17 at 7:30 PM
finance.yahoo.com logoRogers to Participate in Houlihan Lokey Global Industrial Conference
finance.yahoo.com - May 17 at 7:30 PM
nasdaq.com logoRegeneron profit misses estimates as Eylea sales growth slows - Nasdaq
www.nasdaq.com - May 5 at 8:09 AM
finance.yahoo.com logoETFs with exposure to Rogers Corp. : May 4, 2017
finance.yahoo.com - May 4 at 7:50 PM
finance.yahoo.com logoRogers Corp. :ROG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017
finance.yahoo.com - May 3 at 7:23 PM
nasdaq.com logoU.S. FDA approves AstraZeneca's immunotherapy for bladder cancer - Nasdaq
www.nasdaq.com - May 2 at 9:45 AM
marketwatch.com logoRoche revenue rises 4% on strong sales - MarketWatch
www.marketwatch.com - April 27 at 8:01 PM
finance.yahoo.com logoWhy Rogers Corp. Soared Today
finance.yahoo.com - April 27 at 8:01 PM
nasdaq.com logoEMA panel recommends nod for Sanofi, Regeneron's arthritis drug - Nasdaq
www.nasdaq.com - April 23 at 9:08 AM
finance.yahoo.com logoRogers Corp. – Value Analysis (NYSE:ROG) : April 21, 2017
finance.yahoo.com - April 21 at 7:22 PM
finance.yahoo.com logoRogers Corp. breached its 50 day moving average in a Bullish Manner : ROG-US : April 20, 2017
finance.yahoo.com - April 20 at 8:30 AM
finance.yahoo.com logoRogers Schedules First Quarter 2017 Earnings Call for April 27
finance.yahoo.com - April 19 at 7:32 PM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Earns Buy Rating from JPMorgan Chase & Co.
www.americanbankingnews.com - April 18 at 10:37 AM
nasdaq.com logoBristol-Myers to license two drugs to Biogen, Roche - Nasdaq
www.nasdaq.com - April 15 at 8:27 AM
americanbankingnews.com logoJPMorgan Chase & Co. Reaffirms "Buy" Rating for Roche Holding Ltd. (ROG)
www.americanbankingnews.com - April 8 at 5:32 PM
finance.yahoo.com logoTrump's big pharma impact
finance.yahoo.com - April 7 at 12:20 PM
finance.yahoo.com logoRogers Corp. breached its 50 day moving average in a Bearish Manner : ROG-US : April 6, 2017
finance.yahoo.com - April 7 at 12:20 PM
americanbankingnews.com logoRoche Holding's (ROG) "Buy" Rating Reaffirmed at Goldman Sachs Group Inc
www.americanbankingnews.com - March 31 at 7:17 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Rating Reiterated by JPMorgan Chase & Co.
www.americanbankingnews.com - March 30 at 3:45 PM
americanbankingnews.com logoRoche Holding's (ROG) "Buy" Rating Reiterated at Goldman Sachs Group Inc
www.americanbankingnews.com - March 30 at 7:16 AM
americanbankingnews.com logoRoche Holding Ltd. (ROG) Stock Rating Reaffirmed by Goldman Sachs Group Inc
www.americanbankingnews.com - March 27 at 11:38 AM
nasdaq.com logoFDA approves Pfizer, German Merck immunotherapy for skin cancer - Nasdaq
www.nasdaq.com - March 25 at 7:12 PM
thestreet.com logoMylan Settles With Genentech Over Patents for Breast Cancer Drug - TheStreet.com
www.thestreet.com - March 15 at 8:59 AM
nasdaq.com logoBUZZ-US STOCKS ON THE MOVE-Abercrombie, Kroger, PTC, Rada, Broadcom - Nasdaq
www.nasdaq.com - March 2 at 7:44 PM
nasdaq.com logoUPDATE 2-Roche trial finds new drug cocktail cuts breast cancer deaths - Nasdaq
www.nasdaq.com - March 2 at 8:12 AM
nasdaq.com logoNovartis cancer drug Zykadia gets FDA priority review - Nasdaq
www.nasdaq.com - February 23 at 8:20 AM
finance.yahoo.com logoEdited Transcript of ROG earnings conference call or presentation 21-Feb-17 2:00pm GMT
finance.yahoo.com - February 22 at 9:39 AM

Social

Social activity is not available for this stock.
This page was last updated on 6/28/2017 by MarketBeat.com Staff